Boston Scientific (BSX) Didn’t Miss on Demand or Devices. A Cyberattack Just Broke Its Guidance.
A cyberattack disrupted Boston Scientific’s guidance despite no reported shortfall in demand or device performance. The setup shifts attention from operating momentum to the duration, cost and disclosure risk of the incident.
Yahoo Finance said Boston Scientific did not miss on demand or devices, but that a cyberattack disrupted its guidance. The headline did not specify the affected systems, the duration of the disruption, the financial impact or whether the company withdrew, delayed or revised a particular outlook measure.
The reported contrast is between intact underlying demand and a guidance problem caused by the attack. No prior guidance figure, outage timeline or comparison with an earlier forecast was included, so the change in the outlook cannot be quantified from the report.
For Boston Scientific, the direct links are operational: an attack could affect order processing, manufacturing, logistics, billing or the company’s ability to prepare financial forecasts. The company’s FY 2025 revenue was $20.1B, up 19.9% year over year, with a 69.0% gross margin and 14.4% net margin; those figures provide scale but do not establish the incident’s current-quarter effect.
The report did not identify a disputed account or provide a company comment on the attack’s scope. It also did not say whether demand remained intact across all device categories or whether any costs, remediation charges or customer impacts were expected.
The next useful disclosures are the company’s formal update on systems and operations, any revised guidance, and the next earnings release. The key figures will be the duration of disruption, any change to revenue or EPS guidance, incremental remediation costs and evidence of delayed shipments or procedures.
The cyberattack keeps BSX’s demand story intact but moves the near-term risk toward guidance reliability and disruption costs.
The immediate implication is a split read: Boston Scientific’s demand and device performance remain supported by the report, while the cyberattack creates an unquantified risk to forecasting, execution and incident costs. BSX’s FY 2025 revenue growth of 19.9% offers operating momentum, but the available reporting does not establish how much of that trajectory the disruption can affect.
A formal update showing no material operational or financial impact would remove the principal downside, while evidence of shipment delays, remediation costs or withdrawn guidance would deepen it.
CoverageSource: Yahoo Finance · Published here SUN, SEP 13 · 3:31 PM ET · the only report in this recordHow this is decided →
Earlier context and later coverage are dated relative to this report. Automatically linked reports may cover a broader event.
No later reports linked yet.
Follow this story to find new evidence in your Following desk.
BSX retains a strong operating backdrop, with FY 2025 revenue of $20.1B and 19.9% year-over-year growth, while the report says demand and devices did not miss.
The cyberattack has already disrupted guidance, and the report gives no duration or financial-impact estimate, leaving execution and disclosure risk unresolved.
Kept as written · your side, if you take one, is graded privately against licensed closes after 10 trading days · nothing here is advice · How the Wire is made →